Efficacy Analysis of Immunotherapy-based Combinations for EGFR-Mutant Advanced Non-Small Cell Lung Cancer Patients After TKI Failure
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP497894
下载链接
链接失效反馈官方服务：
资源简介：
Treatment for EGFR-mutant advanced NSCLC after TKI failure are limited. Immunotherapy for this disease has been challenging. Our study showed reviewed the efficacy of patients with EGFR-mutant advanced NSCLC who were treated with PD-1 inhibitor-based combinations after TKI failure.
创建时间：
2024-06-03
